Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

Nov 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1566)	2/12/2008 1:38:23 PM
From: Jibacoa	Read Replies (1) of 3722

BSX Is up 1.77% in spite of the verdict against it in the patent infringement suit regarding its Taxus drug-eluting stent products in which the jury awarded damages of $431M. Volume remains relatively moderate at 3,838,790 which is < half its ADV & the stock is trying to get above the $13 level. bigcharts.marketwatch.com BSX believes the jury verdict is unsupported by the evidence & the law, & will try to overturn the verdict, it believes that it will prevail on appeal. The stock is trading around 1.2xBV with + CF; the insiders hold > 10% & institutions around 30%; the short ratio is up about 5% & around 4x its ADV The "analysts" have a target of $14.80 but it seems that with some good news it could easily get to the $16 level bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next